Robbins Arroyo LLP: AxoGen, Inc. (AXGN) Misled Shareholders According to Class Action

Shareholder rights law firm Robbins
Arroyo LLP reminds shareholders that purchasers of AxoGen, Inc.
(NASDAQ: AXGN) filed a class action complaint against the company for
alleged violations of the Securities Exchange Act of 1933 and Securities
Act of 1934 pursuant to the company's November 2017 Secondary Public
Offering ("SPO") and/or May 2018 SPO and/or between August 7, 2017 and
December 18, 2018. AxoGen develops and markets surgical solutions for
peripheral nerves.

View this information on the law firm's Shareholder Rights Blog:
https://www.robbinsarroyo.com/axogen-mar-19/

AxoGen Accused of Overstating Active Accounts and Backdating
Revenue

According to the complaint, AxoGen issued false and misleading
Registration Statements in support of its SPOs in November 2017 and May
2018, that failed to disclose to investors that: (1) the company
increased prices to mask lower sales; (2) the company's pricing
alienated customers and threatened future growth; (3) the company paid
surgeons to generate sales; (4) the company's key metrics were
overstated; and (5) the company lacked adequate internal controls to
prevent such conduct. On December 18, 2018, Seligman Investments
published a report stating, among other things, that former employees
allege channel stuffing and backdating of revenue, that the number of
active accounts may be overstated by a factor of ten, that AxoGen's
"growth is driven by unsustainable, aggressive price increases," and
that the payments to physicians relative to revenue creates "elevated
risks relating to pay-to-play and anti-kickback laws." On this news,
AxoGen stock dropped approximately 22% to close at $21.36 on December
18, 2018.

AxoGen Shareholders Have Legal Options

Concerned shareholders who would like more information about their
rights and potential remedies can contact attorney Leo Kandinov at (800)
350-6003, [email protected],
or via the shareholder
information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in shareholder
rights law. The firm represents individual and institutional investors
in shareholder derivative and securities class action lawsuits, and has
helped its clients realize more than $1 billion of value for themselves
and the companies in which they have invested.

Attorney Advertising. Past results do not guarantee a similar outcome.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190320005592/en/